Sabra Health Care REIT, Inc.
SBRA
$20.42
-$0.15-0.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.93% | -0.31% | 2.52% | 3.65% | 1.39% |
| Total Other Revenue | 25.06% | 21.33% | 20.25% | 20.27% | 19.67% |
| Total Revenue | 10.41% | 9.34% | 10.21% | 10.76% | 9.00% |
| Cost of Revenue | 19.38% | 15.12% | 15.00% | 15.09% | 15.75% |
| Gross Profit | 6.15% | 6.66% | 8.05% | 8.81% | 6.06% |
| SG&A Expenses | 7.28% | -5.36% | -2.67% | 4.19% | 5.47% |
| Depreciation & Amortization | 10.24% | 4.53% | 0.82% | -1.72% | -7.35% |
| Other Operating Expenses | 24,046.77% | -- | -- | -- | -- |
| Total Operating Expenses | 17.89% | 8.83% | 7.21% | 6.95% | 4.66% |
| Operating Income | -2.59% | 10.28% | 15.68% | 17.89% | 17.46% |
| Income Before Tax | 23.20% | 79.86% | 238.78% | 176.68% | 710.49% |
| Income Tax Expenses | 82.79% | 54.38% | -44.23% | -44.12% | -49.80% |
| Earnings from Continuing Operations | 22.73% | 80.15% | 248.73% | 184.38% | 821.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.81% | 80.17% | 248.73% | 184.38% | 821.14% |
| EBIT | -2.59% | 10.28% | 15.68% | 17.89% | 17.46% |
| EBITDA | 2.54% | 8.26% | 9.81% | 9.78% | 6.48% |
| EPS Basic | 19.67% | 76.02% | 240.70% | 179.29% | 809.92% |
| Normalized Basic EPS | 12.90% | 30.33% | 42.30% | 35.47% | 35.53% |
| EPS Diluted | 19.48% | 78.62% | 264.11% | 197.25% | 995.29% |
| Normalized Diluted EPS | 12.66% | 29.98% | 41.59% | 34.72% | 34.54% |
| Average Basic Shares Outstanding | 3.34% | 2.56% | 2.29% | 1.65% | 0.99% |
| Average Diluted Shares Outstanding | 3.58% | 2.89% | 2.83% | 2.23% | 1.72% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.16% | -0.43% | -0.71% | -0.64% | -0.89% |